Metraipolis › archive › dc_88bd50cb92ce

Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection — Europe PMC PMID:41512000

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41512000
DOI
10.1371/journal.pntd.0013597
License (as archived)
solo-consultazione
Archived
2026-11-06T23:02:23.136Z
SHA-256 of the archived text
3655003c257f44f19958f650adf914609bbf231b71f05ba1a1abe5634ebf25a7
Stable URL of this page
https://metraipolis.com/documento/dc_88bd50cb92ce

How to cite

Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection — Europe PMC PMID:41512000 — Europe PMC (en), https://europepmc.org/article/MED/41512000 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_88bd50cb92ce (Metraipolis archive dc_88bd50cb92ce, sha256 3655003c257f44f19958f650adf914609bbf231b71f05ba1a1abe5634ebf25a7)
BibTeX
@misc{dc88bd50cb92ce,
  title = {Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection — Europe PMC PMID:41512000},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41512000},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_88bd50cb92ce; sha256 3655003c257f44f19958f650adf914609bbf231b71f05ba1a1abe5634ebf25a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41512000. Agents can read the archived copy with the MCP tool read_document.